Varian Medical Systems

Rank: 27

2016 Rank31 Employees7,800 Revenue:$3,217,800,000 R&D Spend:$253,500,000 Fiscal year ending:09-30-16 Click here to see all 100

Varian Honored Among World's 100 Most Sustainable Corporations 2015

Varian Selected to Provide Planning Software for New UK Proton Therapy Center.

Key Personnel: Dow Wilson, president & CEO; Jessica Denecour, EVP & CIO; Gary Bischoping Jr., SVP & CFO; Kolleen Kennedy, EVP, oncology systems; Patrick Joda, SVP, global operations; Moataz Karmalawy, VP and general manager, worldwide particle therapy; Dr. Deepak “Dee” Khuntia, SVP and CMO; John Kuo, SVP, general counsel and corporate secretary; Magnus Momsen, SVP and corporate controller; Franco Palomba, SVP, finance and treasurer; Wendy Scott, SVP and chief human resources officer; Rafael Torres, SVP, business development and strategy; Chris Toth, chairman, global commercial & field operations; Vy H. Tran, SVP, regulatory affairs and quality assurance; Corey Zankowski, SVP, CTO; Andrew Whitman, SVP, government affairs;

3100 HANSEN WAY
Palo Alto, California
94304
USA

VISIT THEIR WEBSITE